Capillary physiology of human medulloblastoma: Impact on chemotherapy

Cancer

Volumn 107, Issue 9, 2006, Pages 2223-2227

  Warnke, Peter C ^a,d   Kopitzki, Klaus ^a   Timmer, Jens ^b   Ostertag, Christoph B ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Capillary; Chemotherapy; Medulloblastomas; Physiology

Indexed keywords

IODINE; IOPAMIDOL;

ARTICLE; BLOOD FLOW; BRAIN BLOOD FLOW; CANCER CHEMOTHERAPY; CAPILLARY; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EFFUSION; FEMALE; HUMAN; MALE; MEASUREMENT; MEDULLOBLASTOMA; PLASMA VOLUME; PRIORITY JOURNAL; SCHOOL CHILD; SOLUBILITY; SURFACE PROPERTY; TUMOR BLOOD FLOW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAPILLARIES; CAPILLARY PERMEABILITY; CEREBELLAR NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA;

EID: 33750504219     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22212     Document Type: Article

References (21)

1. Mazzola CA, Pollack IF. Medulloblastoma. Curr Treat Options Neurol. 2003;5:189-198.
2. Packer RJ, Cogen P, Vezina G, Rorke LB. Medulloblastoma: clinical and biologic aspects. Neurooncol. 1999;1:232-250.
3. Dropcho EJ. Novel chemotherapeutic approaches to brain tumors. Hematol Oncol Clin North Am. 2001;15:1027-1052.
4. Kunschner LJ, Kuttesch J, Hess K, Yung WK. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro-oncol. 2001;3:167-173.
5. Mastrangelo S, Tornesello A, Mastrangelo R. Perspectives: chemotherapy of medulloblastoma. Med Pediatr Oncol. 1999; 33:116-119.
6. Packer RJ, Finlay JL. Chemotherapy for childhood medulloblastoma and primitive neuroectodermal tumors. Oncologist. 1996;1:381-393.
7. Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol. 2003;21:1581-1591.
8. Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer. 1990;26:464-469.
9. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978-986.
10. Warnke PC, Timmer J, Ostertag CB, Kopitzki K. Capillary physiology and drug delivery in central nervous system lymphomas. Ann Neurol. 2005;57:136-139.
11. Behrens PF, Ostertag CB, Warnke PC. Regional cerebral blood flow in peritumoral brain edema during dexamethasone treatment: a xenon-enhanced computed tomographic study. Neurosurgery. 1998;43:235-240; discussion 240-231.
12. Li KL, Jackson A. New hybrid technique for accurate and reproducible quantitation of dynamic contrast-enhanced MRI data. Magn Reson Med. 2003;50:1286-1295.
13. Ludemann L, Grieger W, Wurm R, Wust P, Zimmer C. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging. 2005; 23:833-841.
14. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991;17: 357-367.
15. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging. 2005;22:710-717.
16. Parkes LM. Quantification of cerebral perfusion using arterial spin labeling: two-compartment models. J Magn Reson Imaging. 2005;22:732-736.
17. Wong EC, Buxton RB, Frank LR. Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR Biomed. 1997;10:237-249.
18. Warnke PC, Friedman HS, Bigner DD, Groothuis DR. Simultaneous measurements of blood flow and blood-to-tissue transport in xenotransplanted medulloblastomas. Cancer Res. 1987;47:1687-1690.
19. Friedman HS, Colvin OM, Griffith OW, et al. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion. J Natl Cancer Inst. 1989;81: 524-527.
20. Friedman HS, Skapek SX, Colvin OM, et al. Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma. Cancer Res. 1988;48: 5397-5402.
21. Groothuis DR, Blasberg RG. Rational brain tumor chemotherapy. The interaction of drug and tumor. Neurol Clin. 1985;3:801-816.